TEANECK, N.J., April 10, 2012 /PRNewswire/ -- Herborium Group, Inc., (PINKSHEETS: HBRM.PK - News)www.herborium.com, a Botanical Therapeutics® company, announced today that  it has partnered with KAMASUTRA (USA), LLC  to commercialize their  unique natural herbs vodka product in the Fall of 2012.  The vodka formula, label and packaging have already been approved by TTB (Alcohol and Tobacco Tax and Trade Bureau).  Market  share for vodka in the USA is  $4.8 Billion in annual sales with both on premise and home consumption on a rise. This market does not  include any additional potential from the broader liquor market, whose consumers search out innovation and alternative choices in all the products and services they purchase.  KAMASUTRA (USA) LLC is a US partner of the German Bismarck Premium Brands GmbH  www.bismarck.de andhttp://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html. The US version of the product will contain Herborium proprietary herbal formula derived from the Company's sexual health formulations know-how.  

In addition to revenue participation and licensing fees to be received by Herborium Group, the label of each 750ML bottle of the product as well as vodka  promotional materials, will include the link to Herborium proprietary sexual health Botanical Therapeutics® providing unprecedented exposure and  promotional opportunity.  The market for pharmaceutical sexual health products is over 3.2 billion worldwide. The market for natural sexual health products is estimated to be over $1.5 billion, and growing.

In addition there is a growing need for women's sexual health products. The female rsexual enhancement industry is expected to grow into a multibillion dollar business as women themselves become increasingly aware of their sexuality and their sexual health. There is no Viagra comparative product on the market for women and Herborium's Lasting Pleasure® for Women is the ONLY product of its kind.

The sexual enhancement products' trajectory is for long term growth, as is the market for the innovative natural-herbs Vodka segment. 

"As CEO of Kamasutra (USA), LLC, I am passionately looking forward to working with Dr. Agnes P. Olszewski and Herborium Group as I see our combined efforts behind Kamasutra and all that it stands for to be an extraordinary business opportunity, while also a validation of how the experiences of two successful careers in two diverse categories, alcoholic beverages and herbal products when intimately combined, result in something even better for the benefit of satisfying a market desire that we both have identified from our separate strategic viewpoints." Tom Wilen, Kamasutra (USA), LLC CEO

Dr. Agnes Olszewski, Chairman and CEO of Herborium stated: "I believe that this is a great opportunity for Herborium to extend the reach of its herbal know-how to another sector while supporting commercialization of our sexual health products and growing our revenues and brand recognition. We are lucky to partner with such high profile companies as Kamasutra (USA) LLC and Bismarck Premium Brands GmbH, and to benefit from an enormous industry experience represented by Tom Wilen."

About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company markets its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com